DOCOSANOL

Product NDC: 71589-019
11-digit product format: 715890019
Labeler code: 71589
Product ID: 71589-019_79d7df50-7ce1-4679-b638-224ae611969c
Type: HUMAN OTC DRUG
Nonproprietary name: DOCOSANOL
Dosage form: CREAM
Route: TOPICAL
Labeler: Aleor Dermaceuticals Limited
Application: ANDA215839
Marketing category: ANDA
Marketing start: 2022-05-03
Marketing end: 0000-00-00
Substance: DOCOSANOL
Active strength: 100 mg/g
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	71589-019		D	Discontinued by firm	2026-08-17
excluded package	package	71589-019	71589-019-01	D	Discontinued by firm	2026-08-17
excluded package	package	71589-019	71589-019-03	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 45 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	71589-019-03	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	71589-019-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71589-019-03	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71589-019-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71589-019-03	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71589-019-01	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71589-019-03	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71589-019-01	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71589-019-03	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71589-019-01	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71589-019-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71589-019-03	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71589-019-01	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71589-019-03	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71589-019-01	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71589-019-03	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71589-019-01	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71589-019-03	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	71589-019-01	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	71589-019-03	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	71589-019-01	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	71589-019-03	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	71589-019-01	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	71589-019-03	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	71589-019-01	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	71589-019-03	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	71589-019-01	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	71589-019-03	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	71589-019-01	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	71589-019-03	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A215839-001	DOCOSANOL	DOCOSANOL	10%	CREAM / TOPICAL			2022-05-03

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`5c6f7cd8ea54…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A215839-001	DOCOSANOL	10%	CREAM / TOPICAL	2022-05-03	`a50c72e98297…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
71589-019-01	2025-03-12	Docosanol Cream, 10%
71589-019-03	2025-03-12	Docosanol Cream, 10%
71589-019-01	2024-01-30	Docosanol Cream, 10%
71589-019-03	2024-01-30	Docosanol Cream, 10%

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
DOCOSANOL	DOCOSANOL	CVS Pharmacy, Inc.	336b515c-5e7b-4ece-a94f-f8d8e9ce6a7b	2026-03-13	Warnings	Exact identifier application applno (ANDA): 215839 application number: ANDA215839
Docosanol	DOCOSANOL	Leader/ Cardinal Health 110, Inc.	ed18ecb7-70ce-4037-a738-6b159e364d62	2025-12-25	Warnings	Exact identifier application applno (ANDA): 215839 application number: ANDA215839
Docosanol	DOCOSANOL	Alembic Pharmaceuticals Limited	a87a077d-9b0e-490d-b4ac-26c7045828db	2025-05-08	Warnings	Exact identifier application applno (ANDA): 215839 application number: ANDA215839
DOCOSANOL	DOCOSANOL	Rugby Laboratories	6f8d6375-8188-42e9-a048-e8a554122ff3	2024-05-23	Warnings	Exact identifier application applno (ANDA): 215839 application number: ANDA215839
DOCOSANOL	DOCOSANOL	Cosette Pharmaceuticals, Inc.	ccbb5e6d-cb85-449c-a480-28225d744f4d	2024-01-04	Warnings	Exact identifier application applno (ANDA): 215839 application number: ANDA215839
Docosanol	DOCOSANOL	Alembic Pharmaceuticals Inc.	86450000-1810-4739-9801-59beb7c19e67	2023-12-22	Warnings	Exact identifier application applno (ANDA): 215839 application number: ANDA215839

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9G1OE216XY	DOCOSANOL	661-19-8	DOCOSANOL

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
71589-019-01	71589001901	1 TUBE in 1 PACKAGE (71589-019-01) > 2 g in 1 TUBE	1 tube	2022-05-03	0000-00-00	No	No	Current
71589-019-03	71589001903	1 BOTTLE, PUMP in 1 PACKAGE (71589-019-03) > 2 g in 1 BOTTLE, PUMP		2022-05-03	0000-00-00	No	No	Current